REGOSARC: Regorafenib versus placebo in doxorubicin‐refractory soft‐tissue sarcoma—A quality‐adjusted time without symptoms of progression or toxicity analysis von Berry, Vincent, Basson, Laurent, Bogart, Emilie, Mir, Olivier, Blay, Jean‐Yves, Italiano, Antoine, Bertucci, François, Chevreau, Christine, Clisant‐Delaine, Stéphanie, Liegl‐Antzager, Bernadette, Tresch‐Bruneel, Emmanuelle, Wallet, Jennifer, Taieb, Sophie, Decoupigny, Emilie, Cesne, Axel, Brodowicz, Thomas, Penel, Nicolas

Volltext

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial von Pannier, Diane, Adenis, Antoine, Bogart, Emilie, Dansin, Eric, Clisant-Delaine, Stéphanie, Decoupigny, Emilie, Lesoin, Anne, Amela, Eric, Ducornet, Sandrine, Meurant, Jean-Pierre, Le Deley, Marie-Cécile, Penel, Nicolas

Volltext

Activity of regorafenib in patients with non-adipocytic soft tissue sarcoma (NASTS): Evaluation of heterogeneity of treatment effect on the updated analysis of pooled cohorts von Le Deley, Marie-Cecile, Blay, Jean-Yves, Wallet, Jennifer, Bertucci, Francois, Bompas, Emmanuelle, Brodowicz, Thomas, Chaigneau, Loic, Chevreau, Christine, Decoupigny, Emilie, Italiano, Antoine, Lieg-Atzwanger, Bernadette, Mir, Olivier, Piperno-Neumann, Sophie, Thery, Julien, Le Cesne, Axel, Penel, Nicolas

Volltext

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemoth... von Penel, Nicolas, Mir, Olivier, Wallet, Jennifer, Ray-Coquard, Isabelle, Le Cesne, Axel, Italiano, Antoine, Salas, Sebastien, Delcambre, Corinne, Bompas, Emmanuelle, Bertucci, François, Saada-Bouzid, Esma, Chaigneau, Loïc, Chevreau, Christine, Brodowicz, Thomas, Decoupigny, Emilie, Vanseymortier, Marie, Laroche, Lucie, Taieb, Sophie, Le Deley, Marie-Cécile, Blay, Jean-Yves

Volltext

Once weekly associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial von Pannier, Diane, Adenis, Antoine, Bogart, Emilie, Dansin, Eric, Clisant-Delaine, Stéphanie, Decoupigny, Emilie, Lesoin, Anne, Amela, Eric, Ducornet, Sandrine, Meurant, Jean-Pierre, Le Deley, Marie-Cécile, Penel, Nicolas

Volltext

Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a p... von Lebellec, Loic, Bertucci, François, Tresch-Bruneel, Emmanuelle, Bompas, Emmanuelle, Toiron, Yves, Camoin, Luc, Mir, Olivier, Laurence, Valerie, Clisant, Stephanie, Decoupigny, Emilie, Blay, Jean-Yves, Goncalves, Anthony, Penel, Nicolas

Volltext

Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma von Kotecki, Nuria, Le Cesne, Axel, Tresch-Bruneel, Emmanuelle, Ray-Coquard, Isabelle, Chevreau, Christine, Bertucci, François, Bogart, Emilie, Mir, Olivier, Pautier, Patricia, Decoupigny, Emilie, Clisant, Stéphanie, Blay, Jean-Yves, Penel, Nicolas

Volltext

Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma: Long-term Follow-up of the T-DIS trial von Kotecki, Nuria, Le Cesne, Axel, Tresch-Bruneel, Emmanuelle, Ray-Coquard, Isabelle, Chevreau, Christine, Bertucci, François, Bogart, Emilie, Mir, Olivier, Pautier, Patricia, Decoupigny, Emilie, Clisant, Stéphanie, Blay, Jean-Yves, Penel, Nicolas

Volltext

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib (REG) in patients (pts) with nonadipocytic soft tissue sarcoma (STS) pr... von Penel, Nicolas, Blay, Jean-Yves, Wallet, Jennifer, Ray-Coquard, Isabelle Laure, Le Cesne, Axel, Ryckewaert, Thomas, Italiano, Antoine, Salas, Sebastien, Delcambre, Corinne, Bompas, Emmanuelle, Bertucci, Francois, Saada-Bouzid, Esma, Chaigneau, Loic, Chevreau, Christine, Thery, Julien, Decoupigny, Emilie, Vanseymortier, Marie, Le Deley, Marie-Cecile, Mir, Olivier

Volltext

Paclitaxel once weekly (wP) combined with fixed dose of oral metronomic cyclophosphamide (OMC): A dose-escalating phase I trial von Pannier, Diane, Adenis, Antoine, Tresch-Bruneel, Emmanuelle, Bogart, Emilie, El Hajbi, Farid, Dansin, Eric, Kotecki, Nuria, Ceugnart, Luc, Ryckewaert, Thomas, Delaine, Stephanie Clisant, Lauridant Philippin, Geraldine, Lesoin, Anne, Ducornet, Sandrine, Vanseymortier, Marie, Decoupigny, Emilie, Le Deley, Marie-Cecile, Penel, Nicolas

Volltext

Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study von Brodowicz, Thomas, Liegl-Atzwanger, Bernadette, Penel, Nicolas, Mir, Olivier, Blay, Jean-Yves, Kashofer, Karl, Le Cesne, Axel, Decoupigny, Emilie, Wallet, Jennifer, Hamacher, Rainer, Le Deley, Marie-Cecile

Volltext